|
TPST Tempest Therapeutics Inc 1544227 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-27,696,000.00 |
| Balance Sheet |
|
Current Assets
|
$2,446,000.00 |
|
Assets
|
$10,748,000.00 |
|
Current Liabilities
|
$3,311,000.00 |
|
Liabilities
|
$9,926,000.00 |
|
Equity
|
$822,000.00 |
|
Shares Out
|
14344034.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-7,598,000.00 |
| Market Analysis |
Market Cap
|
$12,335,869.24 |
|
Price
|
$0.88 |
|
BVPS
|
0.06 |
|
PB
|
14.33 |
|
EPS
|
-2.53 |
|
FCF
|
$-7,598,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:43 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:43 |
|
| Apr |
May |
Jun |
| 2026-03-30 |
-6.33 |
|
|
2026-05-14 |
-2.53 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-2.07 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-0.79 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TPST documents filed with the SEC.
TPST Filings
Clear
